Quality of Life Assessment in Gynecologic Cancer Patients: An overview

Main Article Content

Chuenkamon Charakorn

Abstract

The treatment of gynecologic malignancies, including endometrial, cervical, ovarian and vulvar cancers, is often incorporating a combination of surgery, chemotherapy, and radiation. The improvement of cancer treatment brings better oncologic outcome. Consequently, the survivors among these patients are increasing. Nowadays, many of cancer researches focus not only the treatment efficacy, but also the quality of life (QOL) of the cancer patients during the process of treatment and afterwards. As a view of gynecologists, we should pay attention to the QOL aspect along with treatment options. Here, we provided a short overview in the QOL assessment in gynecologic cancer patients.

Article Details

How to Cite
(1)
Charakorn, C. Quality of Life Assessment in Gynecologic Cancer Patients: An Overview. Thai J Obstet Gynaecol 2021, 29, 60-64.
Section
Special Article

References

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, 2020. Available from: https://gco.iarc.fr/today, accessed [19 Feb 2021].

Imsamran W, Pattatang A, Supaattagorn P, Chiawiriyabunya I, Namthaisong K, Wongsena M, Puttawibul P, Chitapanarux I, Suwanrungruang K, Sangrajrang S, Buasom R. Cancer in Thailand Vol IX, 2013-2015. Bangkok: New Thammada Press (Thailand) Co., Ltd, 2018.

Imsamran W, Chaiwerawattana A, Wiangnon S, Pongnikorn D, Suwanrungrung K, Sangrajrang S, Buasom R. Cancer in Thailand Vol. VIII, 2010-2012. Bangkok: New Thammada Press (Thailand) Co., Ltd, 2015.

Khuhaprema T, Attasara P, Sriplung H, Wiangnon S, Sangrajrang S. Cancer in Thailand Vol VII, 2007-2009. Bangkok: New Thammada Press (Thailand) Co., Ltd, 2013.

Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res 1996;5:496-502.

Lokich E. Gynecologic Cancer Survivorship. Obstet Gynecol Clin North Am 2019;46:165-78.

Sekse RJT, Dunberger G, Olesen ML, Østerbye M, Seibaek L. Lived experiences and quality of life after gynaecological cancer-An integrative review. J Clin Nurs 2019;28:1393-421.

Wu HS, Harden JK. Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs 2015;38:E29-54.

The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995;41:1403-9.

Haraldstad K, Wahl A, Andenæs R, Andersen JR, Andersen MH, Beisland E, et al. A systematic review of quality of life research in medicine and health sciences. Qual Life Res 2019;28:2641-50.

Valderas JM, Alonso J. Patient reported outcome measures: a model-based classification system for research and clinical practice. Qual Life Res 2008;17:1125-35.

Tax C, Steenbergen ME, Zusterzeel PL, Bekkers RL, Rovers MM. Measuring health-related quality of life in cervical cancer patients: a systematic review of the most used questionnaires and their validity. BMC Med Res Methodol 2017;17:15.

Mokkink LB, Terwee CB, Patrick DL, Alonso J, Stratford PW, Knol DL, et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. J Clin Epidemiol 2010;63: 737-45.

Preston NJ, Wilson N, Wood NJ, Brine J, Ferreira J, Brearley SG. Patient-reported outcome measures for use in gynaecological oncology: a systematic review. BJOG 2015;122:615-22.

Chase DM, Wenzel L. Health-related quality of life in ovarian cancer patients and its impact on clinical management. Expert Rev Pharmacoecon Outcomes Res 2011;11:421-31.

Pfaendler KS, Wenzel L, Mechanic MB, Penner KR. Cervical cancer survivorship: long-term quality of life and social support. Clin Ther 2015;37:39-48.

Luckett T, King M, Butow P, Friedlander M, Paris T. Assessing health-related quality of life in gynecologic oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change. Int J Gynecol Cancer 2010;20:664-84.